Much, much less
We examine which peptides will be reviewed, the regulatory steps that follow the PCAC meeting, and what the outcome could mean for patient access and the broader future of personalized medicine
Extensive studies have shown Epitalon's significant potential in improving sleep quality and reducing oxidative stress
Is peptide therapy covered by insurance
Complete an online questionnaire Because our products are RX, a licensed medical provider will review your needs and approve your medication
The ELAD trial, a randomized, double-blind, placebo-controlled study of 204 patients with mild Alzheimers disease, demonstrated that liraglutide treatment resulted in nearly 50% less brain volume loss in frontal, temporal, parietal, and total gray matter regions compared to placebo, suggesting significant neuroprotective effects [110,118]